Roles of solar uvb and Vitamin D in reducing cancer risk and increasing survival

Anticancer Research

Volumn 36, Issue 3, 2016, Pages 1357-1370

  Grant, William B ^a  

^a Sunlight   (United States)

Author keywords

25 hydroxyVitamin D; Review; Survival; Ultraviolet B; UVB; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D;

BLADDER CANCER; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; DRUG EFFICACY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GALLBLADDER CANCER; GEOGRAPHY; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LATITUDE; LEUKEMIA; LUNG CANCER; METASTASIS; NON MELANOMA SKIN CANCER; NONHODGKIN LYMPHOMA; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RADIATION EXPOSURE; RISK REDUCTION; SEASONAL VARIATION; STOMACH CANCER; SUN EXPOSURE; SURVIVAL RATE; THYROID CANCER; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; VULVA CANCER; ANALOGS AND DERIVATIVES; METABOLISM; MORTALITY; NEOPLASMS; PHOTOTHERAPY; PROCEDURES; RISK; ULTRAVIOLET RADIATION;

HUMANS; NEOPLASMS; RISK; SURVIVAL RATE; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; VITAMIN D;

EID: 84979518010     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (151)

1. Garland CF and Garland FC: Do sunlight and Vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9(3): 227-231, 1980.
2. Garland FC, Garland CF, Gorham ED and Young JF: Geographic variation in breast cancer mortality in the united states: A hypothesis involving exposure to solar radiation. Prev Med 19(6): 614-622, 1990.
3. Lefkowitz ES and Garland CF: Sunlight, Vitamin D, and ovarian cancer mortality rates in us women. Int J Epidemiol 23(6): 1133-1136, 1994.
4. Schwartz GG and Hulka BS: Is Vitamin D deficiency a risk factor for prostate cancer? (hypothesis). Anticancer Res 10(5A): 1307-1311, 1990.
5. Grant WB: An estimate of premature cancer mortality in the u. S. Due to inadequate doses of solar ultraviolet-b radiation. Cancer 94(6): 1867-1875, 2002.
6. Grant WB: Relation between prediagnostic serum 25-hydroxyVitamin D level and incidence of breast, colorectal, and other cancers. J Photochem Photobiol B 101(2): 130-136, 2010.
7. Robsahm TE, Schwartz GG and Tretli S: The inverse relationship between 25-hydroxyVitamin D and cancer survival: Discussion of causation. Cancers (Basel) 5(4): 1439-1455, 2013.
8. Li M, Chen P, Li J, Chu R, Xie D and Wang H: Review: The impacts of circulating 25-hydroxyVitamin D levels on cancer patient outcomes: A systematic review and meta-analysis. J Clin Endocrinol Metab 99(7): 2327-2336, 2014.
9. Toriola AT, Nguyen N, Scheitler-Ring K and Colditz GA: Circulating 25-hydroxyVitamin D levels and prognosis among cancer patients: A systematic review. Cancer Epidemiol Biomarkers Prev 23(6): 917-933, 2014.
10. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR and Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 85(6): 1586-1591, 2007.
11. Bolland MJ, Grey A, Gamble GD and Reid IR: Calcium and Vitamin D supplements and health outcomes: A reanalysis of the women's health initiative (whi) limited-access data set. Am J Clin Nutr 94(4): 1144-1149, 2011.
12. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB and Holick MF: The role of Vitamin D in cancer prevention. Am J Public Health 96(2): 252-261, 2006.
13. Garland CF, Gorham ED, Mohr SB and Garland FC: Vitamin D for cancer prevention: Global perspective. Ann Epidemiol 19(7): 468-483, 2009.
14. Moukayed M and Grant WB: Molecular link between Vitamin D and cancer prevention. Nutrients 5(10): 3993-4021, 2013.
15. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB and Franco OH: Vitamin D and risk of cause specific death: Systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348: g1903, 2014.
16. Shui I and Giovannucci E: Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 810: 33-51, 2014.
17. Giammanco M, Di Majo D, La Guardia M, Aiello S, Crescimannno M, Flandina C, Tumminello FM and Leto G: Vitamin D in cancer chemoprevention. Pharm Biol 53(10): 1399-1434, 2015.
18. Grant WB: A multicountry ecological study of cancer incidence rates in 2008 with respect to various risk-modifying factors. Nutrients 6(1): 163-189, 2014.
19. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P and Hoffmann K: A systematic review of Vitamin D status in populations worldwide. Br J Nutr 111(1): 23-45, 2014.
20. Rebel H, der Spek CD, Salvatori D, van Leeuwen JP, Robanus-Maandag EC and de Gruijl FR: Uv exposure inhibits intestinal tumor growth and progression to malignancy in intestinespecific apc mutant mice kept on low Vitamin D diet. Int J Cancer 136(2): 271-277, 2015.
21. Grant WB: 25-hydroxyVitamin D and breast cancer, colorectal cancer, and colorectal adenomas: Case-control versus nested case-control studies. Anticancer Res 35(2): 1153-1160, 2015.
22. Autier P, Boniol M, Pizot C and Mullie P: Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol 2(1): 76-89, 2014.
23. Wang D, Velez de-la-Paz OI, Zhai JX and Liu DW: Serum 25-hydroxyVitamin D and breast cancer risk: A meta-analysis of prospective studies. Tumour Biol 34(6): 3509-3517, 2013.
24. Grant WB: Effect of interval between serum draw and followup period on relative risk of cancer incidence with respect to 25-hydroxyVitamin D level: Implications for meta-analyses and setting Vitamin D guidelines. Dermatoendocrinol 3(3): 199-204, 2011.
25. Kroll MH, Bi C, Garber CC, Kaufman HW, Liu D, Caston-Balderrama A, Zhang K, Clarke N, Xie M, Reitz RE, Suffin SC and Holick MF: Temporal relationship between Vitamin D status and parathyroid hormone in the united states. PLoS One 10(3): e0118108, 2015.
26. Heaney RP: Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev 72(1): 48-54, 2014.
27. Takahashi E: Stomach cancer and ecologic factors in japan. Tohoku J Exp Med 113(2): 129-133, 1974.
28. Grant WB: How strong is the evidence that solar ultraviolet b and Vitamin D reduce the risk of cancer? An examination using hill's criteria for causality. Dermato-Endocrinology 1(1): 14-21, 2009.
29. Grant WB and Garland CF: The association of solar ultraviolet b (uvb) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26(4A): 2687-2699, 2006.
30. Boscoe FP and Schymura MJ: Solar ultraviolet-b exposure and cancer incidence and mortality in the united states, 1993-2002. BMC Cancer 6: 264, 2006.
31. Mizoue T: Ecological study of solar radiation and cancer mortality in japan. Health Phys 87(5): 532-538, 2004.
32. Chen W, Clements M, Rahman B, Zhang S, Qiao Y and Armstrong BK: Relationship between cancer mortality/incidence and ambient ultraviolet b irradiance in china. Cancer Causes Control 21(10): 1701-1709, 2010.
33. Grant WB: An ecologic study of cancer mortality rates in spain with respect to indices of solar uvb irradiance and smoking. Int J Cancer 120(5): 1123-1128, 2007.
34. Grant WB: An ecological study of cancer incidence and mortality rates in france with respect to latitude, an index for Vitamin D production. Dermatoendocrinol 2(2): 62-67, 2010.
35. Astbury A: Cancer mortality, cosmic ray neutron dose, and summer solar UV-B flux share similar geographical distributions in the USA. Triumf report TRI-PP-05-24. June 2005.
36. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich AE, Fritschi L, Milliken S, Kaldor J, Benke G and Kricker A: Sun exposure may protect against non-hodgkin lymphoma: A casecontrol study. Int J Cancer 112(5): 865-871, 2004.
37. Tran B, Lucas R, Kimlin M, Whiteman D and Neale R: Association between ambient ultraviolet radiation and risk of esophageal cancer. Am J Gastroenterol 107(12): 1803-1813, 2012.
38. Tran B, Jordan SJ, Lucas R, Webb PM and Neale R: Association between ambient ultraviolet radiation and risk of epithelial ovarian cancer. Cancer Prev Res (Phila) 5(11): 1330-1336, 2012.
39. Tran B, Whiteman DC, Webb PM, Fritschi L, Fawcett J, Risch HA, Lucas R, Pandeya N, Schulte A and Neale RE: Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer. Cancer Epidemiol 37(6): 886-892, 2013.
40. Leffell DJ and Brash DE: Sunlight and skin cancer. Sci Am 275(1): 52-53, 56-59, 1996.
41. Xu Y, Shao X, Yao Y, Xu L, Chang L, Jiang Z and Lin Z: Positive association between circulating 25-hydroxyVitamin D levels and prostate cancer risk: New findings from an updated metaanalysis. J Cancer Res Clin Oncol 140(9): 1465-1477, 2014.
42. Nair-Shalliker V, Armstrong BK and Fenech M: Does Vitamin D protect against DNA damage? Mutat Res 733(1-2): 50-57, 2012.
43. Devesa SS, Grauman DJ, Blot WJ, Pennello GA, Hoover RN and Fraumenia JR, Jr.National Institute of Health: Atlas of cancer mortality in the united states, 1950-1994. NIH Publication No. 99-4564 (1999). Figures available at http:ratecalc. cancer. gor/ratecalc/ archivedatlas/; http://ratecalc. cancer. gov/ Accessed January 9, 2016.
44. Murray CJ, Kulkarni SC, Michaud C, Tomijima N, Bulzacchelli MT, Iandiorio TJ and Ezzati M: Eight americas: Investigating mortality disparities across races, counties, and race-counties in the united states. PLoS Med 3(9): e260, 2006.
45. Chen W, Armstrong BK, Rahman B, Zheng R, Zhang S and Clements M: Relationship between cancer survival and ambient ultraviolet b irradiance in china. Cancer Causes Control 24(7): 1323-1330, 2013.
46. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P and Autier P: Meta-analysis of observational studies of serum 25-hydroxyVitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6): 1414-1424, 2011.
47. Helzlsouer KJ and Committee VS: Overview of the cohort consortium Vitamin D pooling project of rarer cancers. Am J Epidemiol 172(1): 4-9, 2010.
48. Chen GC, Zhang ZL, Wan Z, Wang L, Weber P, Eggersdorfer M, Qin LQ and Zhang W: Circulating 25-hydroxyVitamin D and risk of lung cancer: A dose-response meta-analysis. Cancer Causes Control 26(12): 1719-1728, 2015.
49. Zhang L, Wang S, Che X and Li X: Vitamin D and lung cancer risk: A comprehensive review and meta-analysis. Cell Physiol Biochem 36(1): 299-305, 2015.
50. Tretli S, Schwartz GG, Torjesen PA and Robsahm TE: Serum levels of 25-hydroxyVitamin D and survival in norwegian patients with cancer of breast, colon, lung, and lymphoma: A populationbased study. Cancer Causes Control 23(2): 363-370, 2012.
51. Grant WB: Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyVitamin D and all-cause mortality rate. Dermatoendocrinol 4(2): 198-202, 2012.
52. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ and Willett WC: Prospective study of predictors of Vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98(7): 451-459, 2006.
53. Wolpin BM, Ng K, Bao Y, Kraft P, Stampfer MJ, Michaud DS, Ma J, Buring JE, Sesso HD, Lee IM, Rifai N, Cochrane BB, Wactawski-Wende J, Chlebowski RT, Willett WC, Manson JE, Giovannucci EL and Fuchs CS: Plasma 25-hydroxyVitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 21(1): 82-91, 2012.
54. Wong G, Lim WH, Lewis J, Craig JC, Turner R, Zhu K, Lim EM and Prince R: Vitamin D and cancer mortality in elderly women. BMC Cancer 15: 106, 2015.
55. Schottker B, Haug U, Schomburg L, Kohrle J, Perna L, Muller H, Holleczek B and Brenner H: Strong associations of 25-hydroxyVitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 97(4): 782-793, 2013.
56. Stolzenberg-Solomon RZ, Vieth R, Azad A, Pietinen P, Taylor PR, Virtamo J and Albanes D: A prospective nested case-control study of Vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 66(20): 10213-10219, 2006.
57. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW and Silverman DT: Serum Vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 69(4): 1439-1447, 2009.
58. Weinstein SJ, Yu K, Horst RL, Ashby J, Virtamo J and Albanes D: Serum 25-hydroxyVitamin D and risks of colon and rectal cancer in finnish men. Am J Epidemiol 173(5): 499-508, 2011.
59. John EM, Koo J and Schwartz GG: Sun exposure and prostate cancer risk: Evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev 16(6): 1283-1286, 2007.
60. Anderson LN, Cotterchio M, Kirsh VA and Knight JA: Ultraviolet sunlight exposure during adolescence and adulthood and breast cancer risk: A population-based case-control study among ontario women. Am J Epidemiol 174(3): 293-304, 2011.
61. Yang L, Veierod MB, Lof M, Sandin S, Adami HO and Weiderpass E: Prospective study of uv exposure and cancer incidence among swedish women. Cancer Epidemiol Biomarkers Prev 20(7): 1358-1367, 2011.
62. Fuhrman BJ, Freedman DM, Bhatti P, Doody MM, Fu YP, Chang SC, Linet MS and Sigurdson AJ: Sunlight, polymorphisms of Vitamin D-related genes and risk of breast cancer. Anticancer Res 33(2): 543-551, 2013.
63. Blackmore KM, Lesosky M, Barnett H, Raboud JM, Vieth R and Knight JA: Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. Am J Epidemiol 168(8): 915-924, 2008.
64. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC and Clavel-Chapelon F: Joint effects of dietary Vitamin D and sun exposure on breast cancer risk: Results from the french e3n cohort. Cancer Epidemiol Biomarkers Prev 20(1): 187-198, 2011.
65. Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, Spinelli JJ, De Sanjose S, Hartge P, Melbye M, Willett EV, Becker N, Chiu BC, Cerhan JR, Maynadie M, Staines A, Cocco P and Boffeta P: Personal sun exposure and risk of non hodgkin lymphoma: A pooled analysis from the interlymph consortium. Int J Cancer 122(1): 144-154, 2008.
66. Freedman DM, Kimlin MG, Hoffbeck RW, Alexander BH and Linet MS: Multiple indicators of ambient and personal ultraviolet radiation exposure and risk of non-hodgkin lymphoma (united states). J Photochem Photobiol B 101(3): 321-325, 2010.
67. Chang ET, Canchola AJ, Cockburn M, Lu Y, Wang SS, Bernstein L, Clarke CA and Horn-Ross PL: Adulthood residential ultraviolet radiation, sun sensitivity, dietary Vitamin D, and risk of lymphoid malignancies in the california teachers study. Blood 118(6): 1591-1599, 2011.
68. Hughes AM, Lucas RM, Ponsonby AL, Chapman C, Coulthard A, Dear K, Dwyer T, Kilpatrick TJ, McMichael AJ, Pender MP, Taylor BV, Valery P, van der Mei IA and Williams D: The role of latitude, ultraviolet radiation exposure and Vitamin D in childhood asthma and hayfever: An australian multicenter study. Pediatr Allergy Immunol 22(3): 327-333, 2011.
69. Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, Shanafelt TD, Feldman AL, Ansell SM, Macon WR, Herr MM, Wang AH, Nowakowski GS, Call TG, Habermann TM, Slager SL, Witzig TE and Cerhan JR: Early life sun exposure, Vitamin D-related gene variants, and risk of non-hodgkin lymphoma. Cancer Causes Control 23(7): 1017-1029, 2012.
70. Monnereau A, Glaser SL, Schupp CW, Ekstrom Smedby K, de Sanjose S, Kane E, Melbye M, Foretova L, Maynadie M, Staines A, Becker N, Nieters A, Brennan P, Boffetta P, Cocco P, Glimelius I, Clavel J, Hjalgrim H and Chang ET: Exposure to uv radiation and risk of hodgkin lymphoma: A pooled analysis. Blood 122(20): 3492-3499, 2013.
71. Epstein E, Lindqvist PG, Geppert B and Olsson H: A population-based cohort study on sun habits and endometrial cancer. Br J Cancer 101(3): 537-540, 2009.
72. Lu D, Chen J and Jin J: Vitamin D status and risk of nonhodgkin lymphoma: A meta-analysis. Cancer Causes Control 25(11): 1553-1563, 2014.
73. Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Tryggvadottir L, Weiderpass E and Kjaerheim K: Occupation and cancer-follow-up of 15 million people in five nordic countries. Acta Oncol 48(5): 646-790, 2009.
74. Grant WB: Role of solar uvb irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in nordic countries. Dermatoendocrinol 4(2): 203-211, 2012.
75. Friedenreich CM, Neilson HK and Lynch BM: State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 46(14): 2593-2604, 2010.
76. Howard RA, Freedman DM, Park Y, Hollenbeck A, Schatzkin A and Leitzmann MF: Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the nih-aarp diet and health study. Cancer Causes Control 19(9): 939-953, 2008.
77. Cheng J, Chen Y, Wang X, Wang J, Yan Z, Gong G, Li G and Li C: Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancers. Eur J Cancer Prev 24(1): 6-15, 2015.
78. Singh S, Devanna S, Edakkanambeth Varayil J, Murad MH and Iyer PG: Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: A systematic review and meta-analysis. BMC Gastroenterol 14: 101, 2014.
79. Boyle T, Gallagher RP, Gascoyne RD, Connors JM, Le ND and Spinelli JJ: Lifetime physical activity and the risk of nonhodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 24(5): 873-877, 2015.
80. Grant WB: Ultraviolet exposure and non-hodgkin's lymphoma: Beneficial and adverse effects? Cancer Causes Control 23(4): 653-655; author reply 657-658, 2012.
81. Wanner M, Richard A, Martin B, Linseisen J and Rohrmann S: Associations between objective and self-reported physical activity and Vitamin D serum levels in the us population. Cancer Causes Control 26(6): 881-891, 2015.
82. Siegel RL, Sahar L, Portier KM, Ward EM and Jemal A: Cancer death rates in us congressional districts. CA Cancer J Clin 65(5): 339-344, 2015.
83. Ginde AA, Liu MC and Camargo CA, Jr.: Demographic differences and trends of Vitamin D insufficiency in the us population, 1988-2004. Arch Intern Med 169(6): 626-632, 2009.
84. Grant WB and Peiris AN: Differences in Vitamin D status may account for unexplained disparities in cancer survival rates between african and white americans. Dermatoendocrinol 4(2): 85-94, 2012.
85. Hypponen E and Power C: Hypovitaminosis d in british adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85(3): 860-868, 2007.
86. Robsahm TE, Tretli S, Dahlback A and Moan J: Vitamin D3 from sunlight may improve the prognosis of breast-, colon-and prostate cancer (norway). Cancer Causes Control 15(2): 149-158, 2004.
87. Porojnicu AC, Robsahm TE, Ree AH and Moan J: Season of diagnosis is a prognostic factor in hodgkin's lymphoma: A possible role of sun-induced Vitamin D. Br J Cancer 93(5): 571-574, 2005.
88. Lim HS, Roychoudhuri R, Peto J, Schwartz G, Baade P and Moller H: Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer 119: 1530-1536, 2006.
89. Porojnicu A, Robsahm TE, Berg JP and Moan J: Season of diagnosis is a predictor of cancer survival. Sun-induced Vitamin D may be involved: A possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol 103(3-5): 675-678, 2007.
90. Liu XH, Man YN and Wu XZ: Recurrence season impacts the survival of epithelial ovarian cancer patients. Asian Pac J Cancer Prev 15(4): 1627-1632, 2014.
91. Hakko H, Rasanen P, Niemela A, Koivukangas J and Mainio A: Season of tumor surgery in relation to deaths among brain tumor patients: Does sunlight and month of surgery play a role in brain tumor deaths? Acta Neurochir (Wien) 151(11): 1369-1375, 2009.
92. Tampellini M, Polverari RS, Ottone A, Alabiso I, Baratelli C, Bitossi R, Brizzi MP, Leone F, Forti L, Bertona E, Racca P, Mecca C, Alabiso O, Aglietta M, Berruti A and Scagliotti GV: Circannual variation of efficacy outcomes in patients with newly diagnosed metastatic colorectal cancer and treated with first-line chemotherapy. Chronobiol Int 32(10): 1359-1366, 2015.
93. Zgaga L, Theodoratou E, Farrington SM, Din FV, Ooi LY, Glodzik D, Johnston S, Tenesa A, Campbell H and Dunlop MG: Plasma Vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol 32(23): 2430-2439, 2014.
94. Dopico XC, Evangelou M, Ferreira RC, Guo H, Pekalski ML, Smyth DJ, Cooper N, Burren OS, Fulford AJ, Hennig BJ, Prentice AM, Ziegler AG, Bonifacio E, Wallace C and Todd JA: Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat Commun 6: 7000, 2015.
95. Charehbili A, Hamdy NA, Smit VT, Kessels L, van Bochove A, van Laarhoven HW, Putter H, Meershoek-Klein Kranenbarg E, van Leeuwen-Stok AE, van der Hoeven JJ, van de Velde CJ, Nortier JW, Kroep JR and Dutch Breast Cancer Research G: Vitamin D (25-0h d3) status and pathological response to neoadjuvant chemotherapy in stage ii/iii breast cancer: Data from the neozotac trial (boog 10-01). Breast, 2015.
96. Cannell JJ, Grant WB and Holick MF: Vitamin D and inflammation. Dermatoendocrinol 6(1): e983401, 2014.
97. Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN and Goodman MT: Plasma 25-hydroxyVitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: A nested case-control study in the multiethnic cohort study. BMC Cancer 14: 29, 2014.
98. Mohr SB, Gorham ED, Alcaraz JE, Kane CJ, Macera CA, Parsons JK, Wingard DL and Garland CF: Serum 25-hydroxyVitamin D and prevention of breast cancer: Pooled analysis. Anticancer Res 31(9): 2939-2948, 2011.
99. Mohr SB, Gorham ED, Kim J, Hofflich H, Cuomo RE and Garland CF: Could Vitamin D sufficiency improve the survival of colorectal cancer patients? J Steroid Biochem Mol Biol 148: 239-244, 2015.
100. Wang W, Li G, He X, Gao J, Wang R, Wang Y and Zhao W: Serum 25-hydroxyVitamin D levels and prognosis in hematological malignancies: A systematic review and metaanalysis. Cell Physiol Biochem 35(5): 1999-2005, 2015.
101. Ren C, Qiu MZ, Wang DS, Luo HY, Zhang DS, Wang ZQ, Wang FH, Li YH, Zhou ZW and Xu RH: Prognostic effects of 25-hydroxyVitamin D levels in gastric cancer. J Transl Med 10: 16, 2012.
102. Meyer F, Liu G, Douville P, Samson E, Xu W, Adjei A and Bairati I: Dietary Vitamin D intake and serum 25-hydroxyVitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer 128(7): 1741-1746, 2011.
103. Gugatschka M, Kiesler K, Obermayer-Pietsch B, Groselj-Strele A, Griesbacher A and Friedrich G: Vitamin D status is associated with disease-free survival and overall survival time in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Arch Otorhinolaryngol 268(8): 1201-1204, 2011.
104. Bade B, Zdebik A, Wagenpfeil S, Graber S, Geisel J, Vogt T and Reichrath J: Low serum 25-hydroxyVitamin D concentrations are associated with increased risk for melanoma and unfavourable prognosis. PLoS One 9(12): e112863, 2014.
105. Webb PM, de Fazio A, Protani MM, Ibiebele TI, Nagle CM, Brand AH, Blomfield PI, Grant P, Perrin LC, Neale RE and Australian Ovarian Cancer Study G: Circulating 25-hydroxyVitamin D and survival in women with ovarian cancer. Am J Clin Nutr 102(1): 109-114, 2015.
106. Muller DC, Scelo G, Zaridze D, Janout V, Holcatova I, Navratilova M, Mates D, Midttun O, Ueland PM, Brennan P and Johansson M: Circulating 25-hydroxyVitamin D3 and survival after diagnosis with kidney cancer. Cancer Epidemiol Biomarkers Prev 24(8): 1277-1281, 2015.
107. Wesa KM, Segal NH, Cronin AM, Sjoberg DD, Jacobs GN, Coleton MI, Fleisher M, Dnistrian AM, Saltz LB and Cassileth BR: Serum 25-hydroxy Vitamin D and survival in advanced colorectal cancer: A retrospective analysis. Nutr Cancer 67(3): 424-430, 2015.
108. Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, Saldana-Quiroz VA and Romieu I: Serum 25-hydroxyVitamin D and risk of breast cancer: Results of a large population-based case-control study in mexican women. Cancer Causes Control 23(7): 1149-1162, 2012.
109. Newton-Bishop JA, Beswick S, Randerson-Moor J, Chang YM, Affleck P, Elliott F, Chan M, Leake S, Karpavicius B, Haynes S, Kukalizch K, Whitaker L, Jackson S, Gerry E, Nolan C, Bertram C, Marsden J, Elder DE, Barrett JH and Bishop DT: Serum 25-hydroxyVitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 27(32): 5439-5444, 2009.
110. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA and Giovannucci E: Prediagnostic plasma Vitamin D metabolites and mortality among patients with prostate cancer. PLoS One 6(4): e18625, 2011.
111. Muller DC, Fanidi A, Midttun O, Steffen A, Dossus L, Boutron-Ruault MC, Severi G, Kuhn T, Katzke V, de la Torre RA, Gonzalez CA, Sanchez MJ, Dorronsoro M, Santiuste C, Barricarte A, Khaw KT, Wareham N, Travis RC, Trichopoulou A, Giotaki M, Trichopoulos D, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Peeters PH, Ljungberg B, Wennberg M, Weiderpass E, Murphy N, Riboli E, Ueland PM, Boeing H, Brennan P and Johansson M: Circulating 25-hydroxyVitamin D3 in relation to renal cell carcinoma incidence and survival in the epic cohort. Am J Epidemiol 180(8): 810-820, 2014.
112. Mursu J, Nurmi T, Voutilainen S, Tuomainen TP and Virtanen JK: The association between serum 25-hydroxyVitamin D3 concentration and risk of disease death in men: Modification by magnesium intake. Eur J Epidemiol 30(4): 343-347, 2015.
113. Obermannova R, Dusek L, Greplova K, Jarkovsky J, Sterba J, Vyzula R, Demlova R, Zdrazilova-Dubska L and Valik D: Timecourse pattern of blood 25-hydroxycholecalciferol is a significant predictor of survival outcome in metastatic colorectal cancer: A clinical practice-based study. Neoplasma 62(6): 958-965, 2015.
114. Gocek E and Studzinski GP: Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci 46(4): 190-209, 2009.
115. Stubbins RE, Hakeem A and Nunez NP: Using components of the Vitamin D pathway to prevent and treat colon cancer. Nutr Rev 70(12): 721-729, 2012.
116. Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X, Chen L, Zhou S, Goltzman D, Miao D and Wu E: 1, 25(oh)(2)d(3) inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes. Curr Med Chem 20(33): 4131-4141, 2013.
117. Nakagawa K, Kawaura A, Kato S, Takeda E and Okano T: 1 alpha, 25-dihydroxyVitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 26(2): 429-440, 2005.
118. Halder SK, Osteen KG and Al-Hendy A: Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and-9 in human uterine fibroid cells. Hum Reprod 28(9): 2407-2416, 2013.
119. Prevarskaya N, Skryma R and Shuba Y: Calcium in tumour metastasis: New roles for known actors. Nat Rev Cancer 11(8): 609-618, 2011.
120. Berridge MJ: Vitamin D cell signalling in health and disease. Biochem Biophys Res Commun 460(1): 53-71, 2015.
121. Raimondi S, Pasquali E, Gnagnarella P, Serrano D, Disalvatore D, Johansson HA and Gandini S: Bsmi polymorphism of Vitamin D receptor gene and cancer risk: A comprehensive metaanalysis. Mutat Res 769: 17-34, 2014.
122. Gnagnarella P, Pasquali E, Serrano D, Raimondi S, Disalvatore D and Gandini S: Vitamin D receptor polymorphism foki and cancer risk: A comprehensive meta-analysis. Carcinogenesis 35(9): 1913-1919, 2014.
123. Serrano D, Gnagnarella P, Raimondi S and Gandini S: Metaanalysis on Vitamin D receptor and cancer risk: Focus on the role of taqi, apai, and cdx2 polymorphisms. Eur J Cancer Prev 25(1): 85-96, 2016.
124. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM and Hewison M: Extrarenal expression of 25-hydroxyVitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86(2): 888-894, 2001.
125. Baggerly CA, Cuomo RE, French CB, Garland CF, Gorham ED, Grant WB, Heaney RP, Holick MF, Hollis BW, McDonnell SL, Pittaway M, Seaton P, Wagner CL and Wunsch A: Sunlight and Vitamin D: Necessary for public health. J Am Coll Nutr 34(4): 359-365, 2015.
126. Tisdale MJ: Mechanisms of cancer cachexia. Physiol Rev 89(2): 381-410, 2009.
127. Fearon KC: Cancer cachexia: Developing multimodal therapy for a multidimensional problem. Eur J Cancer 44(8): 1124-1132, 2008.
128. Camacho DF and Pienta KJ: Disrupting the networks of cancer. Clin Cancer Res 18(10): 2801-2808, 2012.
129. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G and Boissier MC: Vitamin D and inflammation. Joint Bone Spine 77(6): 552-557, 2010.
130. Polly P and Tan TC: The role of Vitamin D in skeletal and cardiac muscle function. Front Physiol 5: 145, 2014.
131. Hopkins MH, Owen J, Ahearn T, Fedirko V, Flanders WD, Jones DP and Bostick RM: Effects of supplemental Vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: A randomized, controlled clinical trial. Cancer Prev Res (Phila) 4(10): 1645-1654, 2011.
132. Marshall DT, Savage SJ, Garrett-Mayer E, Keane TE, Hollis BW, Horst RL, Ambrose LH, Kindy MS and Gattoni-Celli S: Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab 97(7): 2315-2324, 2012.
133. Ng K, Scott JB, Drake BF, Chan AT, Hollis BW, Chandler PD, Bennett GG, Giovannucci EL, Gonzalez-Suarez E, Meyerhardt JA, Emmons KM and Fuchs CS: Dose response to Vitamin D supplementation in african americans: Results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr 99(3): 587-598, 2014.
134. Poole EM, Shu X, Caan BJ, Flatt SW, Holmes MD, Lu W, Kwan ML, Nechuta SJ, Pierce JP and Chen WY: Postdiagnosis supplement use and breast cancer prognosis in the after breast cancer pooling project. Breast Cancer Res Treat 139(2): 529-537, 2013.
135. Zeichner SB, Koru-Sengul T, Shah N, Liu Q, Markward NJ, Montero AJ, Gluck S, Silva O and Ahn ER: Improved clinical outcomes associated with Vitamin D supplementation during adjuvant chemotherapy in patients with her2+ nonmetastatic breast cancer. Clin Breast Cancer 15(1): e1-11, 2015.
136. Tomiska M, Novotna S, Klvacova L, Tumova J and Janikova A: Vitamin D during cancer treatment. Klin Onkol 28(2): 99-104, 2015.
137. Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL and Sesso HD: Circulating 25-hydroxyVitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5(6): 819-829, 2012.
138. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE and Hu FB: Blood 25-hydroxy Vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care 36(5): 1422-1428, 2013.
139. Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, Baggerly L, Hofflich H, Ramsdell JW, Zeng K and Heaney RP: Meta-analysis of all-cause mortality according to serum 25-hydroxyVitamin D. Am J Public Health 104(8): e43-50, 2014.
140. Grober U, Spitz J, Reichrath J, Kisters K and Holick MF: Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare. Dermatoendocrinol 5(3): 331-347, 2013.
141. Hossein-nezhad A and Holick MF: Vitamin D for health: A global perspective. Mayo Clin Proc 88(7): 720-755, 2013.
142. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K and Soni M: Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12(10): 976-989, 2013.
143. Lewis C, Xun P and He K: Vitamin D supplementation and quality of life following diagnosis in stage ii colorectal cancer patients: A 24-month prospective study. Support Care Cancer, 2015.
144. Soki FN, Park SI and McCauley LK: The multifaceted actions of pthrp in skeletal metastasis. Future Oncol 8(7): 803-817, 2012.
145. Erdogan B and Cicin I: Medical treatment of breast cancer bone metastasis: From bisphosphonates to targeted drugs. Asian Pac J Cancer Prev 15(4): 1503-1510, 2014.
146. Amir E, Simmons CE, Freedman OC, Dranitsaris G, Cole DE, Vieth R, Ooi WS and Clemons M: A phase 2 trial exploring the effects of high-dose (10, 000 iu/day) Vitamin D(3) in breast cancer patients with bone metastases. Cancer 116(2): 284-291, 2010.
147. Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D and Adams JS: Vitamin D-mediated hypercalcemia in lymphoma: Evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18(3): 579-582, 2003.
148. Hill AB: The environment and disease: Association or causation? Proc R Soc Med 58: 295-300, 1965.
149. Potischman N and Weed DL: Causal criteria in nutritional epidemiology. Am J Clin Nutr 69(6): 1309S-1314S, 1999.
150. Grant WB: How strong is the evidence that solar ultraviolet b and Vitamin D reduce the risk of cancer?: An examination using hill's criteria for causality. Dermatoendocrinol 1(1): 17-24, 2009.
151. Mohr SB, Gorham ED, Alcaraz JE, Kane CI, Macera CA, Parsons JK, Wingard DL and Garland CF: Does the evidence for an inverse relationship between serum Vitamin D status and breast cancer risk satisfy the hill criteria? Dermatoendocrinol 4(2): 152-157, 2012.